|
Market Closed -
NYSE
16:01:45 2026-11-06 EST
|
Pre-market 08:55:16 | |||
| 291.31 USD | +1.07% |
|
294.60 | +1.13% |
| 07:24am | AbbVie Unit Says GLP-1 Patients Report Improved Satisfaction With Facial Appearance in 2 Studies | MT |
| 11-07 | J&J's once-daily pill eases psoriatic arthritis symptoms in late-stage trial | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 515B | |||||
| 1,206B | |||||
| 665B | |||||
| 381B | |||||
| 362B | |||||
| 307B |
- Stock Market
- Stocks
- ABBV Stock
- Charts AbbVie Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
